{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:00:49Z","timestamp":1778770849527,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40618-020-01339-w","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T04:25:44Z","timestamp":1592972744000},"page":"541-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Success rate of radioactive iodine treatment for children and adolescent with hyperthyroidism"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1332-0903","authenticated-orcid":false,"given":"S.","family":"Namwongprom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Dejkhamron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Unachak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"issue":"2","key":"1339_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/thy.1991.1.129","volume":"1","author":"L Wartofsky","year":"1991","unstructured":"Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y, Izumi M (1991) Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid 1(2):129\u2013135. https:\/\/doi.org\/10.1089\/thy.1991.1.129","journal-title":"Thyroid"},{"issue":"3","key":"1339_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1365-2265.1998.00558.x","volume":"49","author":"NJ Leech","year":"1998","unstructured":"Leech NJ, Dayan CM (1998) Controversies in the management of Graves' disease. Clin Endocrinol 49(3):273\u2013280. https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00558.x","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1339_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1530\/EJE-07-0450","volume":"158","author":"P Laurberg","year":"2008","unstructured":"Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Torring O (2008) TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158(1):69\u201375. https:\/\/doi.org\/10.1530\/EJE-07-0450","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1339_CR4","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1210\/jc.2009-0747","volume":"94","author":"F Traisk","year":"2009","unstructured":"Traisk F, Tallstedt L, Abraham-Nordling M, Andersson T, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nystrom E, Ponjavic V, Taube A, Torring O, Wallin G, Asman P, Lundell G, Thyroid Study Group of TT (2009) Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab 94(10):3700\u20133707. https:\/\/doi.org\/10.1210\/jc.2009-0747","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1339_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4274\/Jcrpe.951","volume":"5","author":"S Namwongprom","year":"2013","unstructured":"Namwongprom S, Unachak K, Dejkhamron P, Ua-apisitwong S, Ekmahachai M (2013) Radioactive iodine for thyrotoxicosis in childhood and adolescence: treatment and outcomes. J Clin Res Pediatr Endocrinol 5(2):95\u201397. https:\/\/doi.org\/10.4274\/Jcrpe.951","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"41","key":"1339_CR6","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1055\/s-2008-1070506","volume":"106","author":"J Brunn","year":"1981","unstructured":"Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC (1981) Volumetric analysis of thyroid lobes by real-time ultrasound (author's transl). Dtsch Med Wochenschr 106(41):1338\u20131340. https:\/\/doi.org\/10.1055\/s-2008-1070506","journal-title":"Dtsch Med Wochenschr"},{"issue":"9","key":"1339_CR7","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1515\/jpem.2006.19.9.1095","volume":"19","author":"SA Rivkees","year":"2006","unstructured":"Rivkees SA (2006) The treatment of Graves' disease in children. J Pediatr Endocrinol Metab 19(9):1095\u20131111. https:\/\/doi.org\/10.1515\/jpem.2006.19.9.1095","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5","key":"1339_CR8","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1210\/jcem-60-5-1019","volume":"60","author":"JI Hamburger","year":"1985","unstructured":"Hamburger JI (1985) Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab 60(5):1019\u20131024. https:\/\/doi.org\/10.1210\/jcem-60-5-1019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1339_CR9","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1210\/jcem.82.6.3986","volume":"82","author":"NS Glaser","year":"1997","unstructured":"Glaser NS, Styne DM (1997) Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 82(6):1719\u20131726. https:\/\/doi.org\/10.1210\/jcem.82.6.3986","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1339_CR10","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1542\/peds.2007-1535","volume":"121","author":"NS Glaser","year":"2008","unstructured":"Glaser NS, Styne DM, Organization of Pediatric Endocrinologists of Northern California Collaborative Graves' Disease Study G (2008) Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study. Pediatrics 121(3):e481\u2013488. https:\/\/doi.org\/10.1542\/peds.2007-1535","journal-title":"Pediatrics"},{"issue":"10","key":"1339_CR11","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1210\/jc.2008-0842","volume":"93","author":"F Kaguelidou","year":"2008","unstructured":"Kaguelidou F, Alberti C, Castanet M, Guitteny MA, Czernichow P, Leger J, French Childhood Graves' Disease Study G (2008) Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. J Clin Endocrinol Metab 93(10):3817\u20133826. https:\/\/doi.org\/10.1210\/jc.2008-0842","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1339_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1001\/jama.280.4.347","volume":"280","author":"E Ron","year":"1998","unstructured":"Ron E, Doody MM, Becker DV, Brill AB, Curtis RE, Goldman MB, Harris BS 3rd, Hoffman DA, McConahey WM, Maxon HR, Preston-Martin S, Warshauer ME, Wong FL, Boice JD Jr (1998) Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA 280(4):347\u2013355. https:\/\/doi.org\/10.1001\/jama.280.4.347","journal-title":"JAMA"},{"issue":"3","key":"1339_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1210\/jc.2006-1239","volume":"92","author":"SA Rivkees","year":"2007","unstructured":"Rivkees SA, Dinauer C (2007) An optimal treatment for pediatric Graves' disease is radioiodine. J Clin Endocrinol Metab 92(3):797\u2013800. https:\/\/doi.org\/10.1210\/jc.2006-1239","journal-title":"J Clin Endocrinol Metab"},{"key":"1339_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006294.pub2","author":"C Ma","year":"2008","unstructured":"Ma C, Kuang A, Xie J, Liu G (2008) Radioiodine treatment for pediatric Graves' disease. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD006294.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1339_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1067\/mpd.2002.125494","volume":"141","author":"TD Nebesio","year":"2002","unstructured":"Nebesio TD, Siddiqui AR, Pescovitz OH, Eugster EA (2002) Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children. J Pediatr 141(1):99\u2013103. https:\/\/doi.org\/10.1067\/mpd.2002.125494","journal-title":"J Pediatr"},{"issue":"4 Pt 1","key":"1339_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1542\/peds.111.4.745","volume":"111","author":"SA Rivkees","year":"2003","unstructured":"Rivkees SA, Cornelius EA (2003) Influence of iodine-131 dose on the outcome of hyperthyroidism in children. Pediatrics 111(4 Pt 1):745\u2013749. https:\/\/doi.org\/10.1542\/peds.111.4.745","journal-title":"Pediatrics"},{"issue":"8","key":"1339_CR17","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1210\/jcem.86.8.7781","volume":"86","author":"A Allahabadia","year":"2001","unstructured":"Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA (2001) Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab 86(8):3611\u20133617. https:\/\/doi.org\/10.1210\/jcem.86.8.7781","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1339_CR18","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1210\/jcem.83.11.5239","volume":"83","author":"SA Rivkees","year":"1998","unstructured":"Rivkees SA, Sklar C, Freemark M (1998) Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 83(11):3767\u20133776. https:\/\/doi.org\/10.1210\/jcem.83.11.5239","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1339_CR19","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s40618-016-0477-x","volume":"39","author":"SA Rivkees","year":"2016","unstructured":"Rivkees SA (2016) Controversies in the management of Graves' disease in children. J Endocrinol Invest 39(11):1247\u20131257. https:\/\/doi.org\/10.1007\/s40618-016-0477-x","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1339_CR20","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3949\/ccjm.55.4.373","volume":"55","author":"WJ Levy","year":"1988","unstructured":"Levy WJ, Schumacher OP, Gupta M (1988) Treatment of childhood Graves' disease. A review with emphasis on radioiodine treatment. Cleve Clin J Med 55(4):373\u2013382. https:\/\/doi.org\/10.3949\/ccjm.55.4.373","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"1339_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1515\/jpem-2017-0394","volume":"31","author":"F Azizi","year":"2018","unstructured":"Azizi F, Amouzegar A (2018) Management of thyrotoxicosis in children and adolescents: 35 years' experience in 304 patients. J Pediatr Endocrinol Metab 31(2):159\u2013165. https:\/\/doi.org\/10.1515\/jpem-2017-0394","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"1339_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1515\/jpem-2019-0316","volume":"33","author":"PB Kaplowitz","year":"2020","unstructured":"Kaplowitz PB, Jiang J, Vaidyanathan P (2020) Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period. J Pediatr Endocrinol Metab 33(3):383\u2013389. https:\/\/doi.org\/10.1515\/jpem-2019-0316","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"1339_CR23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ando.2018.08.001","volume":"79","author":"J Leger","year":"2018","unstructured":"Leger J, Oliver I, Rodrigue D, Lambert AS, Coutant R (2018) Graves' disease in children. Ann Endocrinol 79(6):647\u2013655. https:\/\/doi.org\/10.1016\/j.ando.2018.08.001","journal-title":"Ann Endocrinol"},{"issue":"11","key":"1339_CR24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1080\/17512433.2018.1546576","volume":"11","author":"F De Luca","year":"2018","unstructured":"De Luca F, Valenzise M (2018) Controversies in the pharmacological treatment of Graves' disease in children. Expert Rev Clin Pharmacol 11(11):1113\u20131121. https:\/\/doi.org\/10.1080\/17512433.2018.1546576","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"1339_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/cen.13873","volume":"90","author":"ET Aung","year":"2019","unstructured":"Aung ET, Zammitt NN, Dover AR, Strachan MWJ, Seckl JR, Gibb FW (2019) Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis. Clin Endocrinol 90(1):192\u2013199. https:\/\/doi.org\/10.1111\/cen.13873","journal-title":"Clin Endocrinol"},{"issue":"11","key":"1339_CR26","first-page":"1815","volume":"37","author":"R Aktay","year":"1996","unstructured":"Aktay R, Rezai K, Seabold JE, Bar RS, Kirchner PT (1996) Four- to twenty-four-hour uptake ratio: an index of rapid iodine-131 turnover in hyperthyroidism. J Nucl Med 37(11):1815\u20131819","journal-title":"J Nucl Med"},{"issue":"6","key":"1339_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/BF03348615","volume":"13","author":"C Marcocci","year":"1990","unstructured":"Marcocci C, Gianchecchi D, Masini I, Golia F, Ceccarelli C, Bracci E, Fenzi GF, Pinchera A (1990) A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 13(6):513\u2013520. https:\/\/doi.org\/10.1007\/BF03348615","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1339_CR28","first-page":"2","volume":"13","author":"JW van Isselt","year":"2010","unstructured":"van Isselt JW, Broekhuizen-de Gast HS (2010) The radioiodine turnover rate as a determinant of radioiodine treatment outcome in Graves' disease. Hell J Nucl Med 13(1):2\u20135","journal-title":"Hell J Nucl Med"},{"issue":"2","key":"1339_CR29","first-page":"228","volume":"37","author":"GE Berg","year":"1996","unstructured":"Berg GE, Michanek AM, Holmberg EC, Fink M (1996) Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med 37(2):228\u2013232","journal-title":"J Nucl Med"},{"issue":"1","key":"1339_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/MED.0000000000000521","volume":"27","author":"PB Kaplowitz","year":"2020","unstructured":"Kaplowitz PB, Vaidyanathan P (2020) Update on pediatric hyperthyroidism. Curr Opin Endocrinol Diabetes Obes 27(1):70\u201376. https:\/\/doi.org\/10.1097\/MED.0000000000000521","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"6","key":"1339_CR31","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/j.1365-2265.2009.03565.x","volume":"71","author":"S McCormack","year":"2009","unstructured":"McCormack S, Mitchell DM, Woo M, Levitsky LL, Ross DS, Misra M (2009) Radioactive iodine for hyperthyroidism in children and adolescents: referral rate and response to treatment. Clin Endocrinol 71(6):884\u2013891. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03565.x","journal-title":"Clin Endocrinol"},{"issue":"9821","key":"1339_CR32","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(11)60782-4","volume":"379","author":"JA Franklyn","year":"2012","unstructured":"Franklyn JA, Boelaert K (2012) Thyrotoxicosis. Lancet 379(9821):1155\u20131166. https:\/\/doi.org\/10.1016\/S0140-6736(11)60782-4","journal-title":"Lancet"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01339-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01339-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01339-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:04:54Z","timestamp":1624493094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01339-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1339"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01339-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of Faculty of Medicine, Chiang Mai University, Thailand approved this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, inform consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}